This is an example of
...
| Note |
|---|
The ADaM ADSL associated with this study are not shown. An example on the creation of an ADLS for another study is provided here ADaM Example.ADSL Analysis Data Subject Level New |
...
...
integer
...
the ADVS dataset and associated metadata. This is just an example and does not mean to indicate that ADVS must be used as the dataset name, nor are the parameters described necessarily those that would be used in a particular study.
...
| Dataset wrap |
|---|
|
| Dataset2 |
|---|
| STUDYID | USUBJID | TRTP | TRT01P | TRTA | TRT01A | ADT | ADTM | ADY | AVISIT | AVISITN | ATPT | ATPTN | APHASE | PARAM | PARAMCD | PARAMN | AVAL | BASE | CHG | PCHG | DTYPE | ABLFL | ANL01FL | SAFFL | RANDFL | TRTSDT | TRTEDT | VSSEQ | VSTESTCD | VSTEST |
|---|
|
|
| VSSTAT | VSREASND | VSLOC | VSLAT | VSLOBXFL | VISITNUM | VISIT | VSDTC | VSDY | VSTPT | VSTPTNUM |
|---|
|
|
...
| A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 | 01JAN2021 |
|
|
...
...
| -6 | Baseline | 1 | Baseline 1 | 1 | SCREENING | Systolic Blood Pressure (mmHg) | SYSBP | 4 | 154 |
|
|
|
|
| Y | Y | Y | 2021-01-08 | 2021-01-28 | 1 | SYSBP | Systolic Blood Pressure |
|
|
...
...
...
...
...
...
...
| A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 | 01JAN2021 |
|
|
...
...
| -6 | Baseline | 1 | Baseline 2 | 2 | SCREENING | Systolic Blood Pressure (mmHg) | SYSBP | 4 | 152 |
|
|
|
|
| Y | Y | Y | 2021-01-08 | 2021-01-28 | 2 | SYSBP | Systolic Blood Pressure |
|
|
...
...
...
...
...
...
| A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 |
| -6 |
|
|
...
| Baseline | 1 |
|
| SCREENING | Systolic Blood Pressure (mmHg) | SYSBP | 4 | 153 | 153 | 0 |
| AVERAGE | Y |
|
|
...
| Y | Y | Y | 2021-01-08 | 2021-01-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| | A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 | 01JAN2021 |
|
|
...
...
| -6 | Baseline | 1 | Baseline 1 | 1 | SCREENING | Diastolic Blood Pressure (mmHg) | DIABP | 1 | 44 |
|
|
|
|
| Y | Y | Y | 2021-01-08 | 2021-01-28 | 3 | DIABP | Diastolic Blood Pressure |
|
|
...
...
...
...
...
...
...
| A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 | 01JAN2021 |
|
|
...
...
| -6 | Baseline | 1 | Baseline 2 | 2 | SCREENING | Diastolic Blood Pressure (mmHg) | DIABP | 1 | 48 |
|
|
|
|
| Y | Y | Y | 2021-01-08 | 2021-01-28 | 4 | DIABP | Diastolic Blood Pressure |
|
|
...
...
...
...
...
...
...
| A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 |
| -6 |
|
|
...
| Baseline | 1 |
|
| SCREENING | Diastolic Blood Pressure (mmHg) | DIABP | 1 | 46 | 46 | 0 |
| AVERAGE | Y | Y | Y |
|
|
...
| Y | 2021-01-08 | 2021-01-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| | A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 |
| -6 |
|
|
...
| Baseline | 1 |
|
| SCREENING | Pulse Rate (beats/min) | PULSE | 3 | 72 | 72 | 0 |
|
| Y |
|
|
...
...
...
| Y | 2021-01-08 | 2021-01-28 | 5 | PULSE | Pulse Rate |
|
| ARM | LEFT | Y | 1 | Baseline |
|
|
...
...
...
| 02T08:45 | -6 |
|
| | A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 | 01JAN2021 |
|
|
...
...
| -6 | Baseline | 1 | Baseline 1 | 1 | SCREENING | Temperature (C) | TEMP | 5 | 34.7 |
|
|
...
...
...
| Y | 2021-01-08 | 2021-01-28 | 6 | TEMP | Temperature |
|
|
...
|
|
| SUBLINGUAL REGION |
|
| 1 | Baseline |
|
|
...
...
...
...
...
| A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 | 01JAN2021 |
|
|
...
...
| -6 | Baseline | 1 | Baseline 2 | 2 | SCREENING | Temperature (C) | TEMP | 5 | 36.2 |
|
|
...
...
...
| Y | 2021-01-08 | 2021-01-28 | 7 | TEMP | Temperature |
|
|
...
|
|
| SUBLINGUAL REGION |
| Y | 1 | Baseline |
|
|
...
...
...
...
...
| A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 |
| -6 |
|
|
...
| Baseline | 1 |
|
| SCREENING | Temperature (C) | TEMP | 5 | 35.45 | 35.45 | 0 |
| AVERAGE | Y | Y | Y |
|
|
...
| Y | 2021-01-08 | 2021-01-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| | A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 |
| -6 |
|
|
...
| Baseline | 1 |
|
| SCREENING | Weight (kg) | WEIGHT | 6 | 90.5 | 90.5 | 0 |
|
| Y |
|
|
...
...
...
| Y | 2021-01-08 | 2021-01-28 | 8 | WEIGHT | Weight |
|
|
...
...
...
...
...
...
|
| | A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 02JAN2021 |
| -6 |
|
|
...
| Baseline | 1 |
|
| SCREENING | Height (cm) | HEIGHT | 2 | 157 | 157 | 0 |
|
| Y |
|
|
...
...
...
| Y | 2021-01-08 | 2021-01-28 | 9 | HEIGHT | Height |
|
|
|
| Y | 1 | Baseline |
|
|
...
...
...
...
...
21JIL1999
|
| | A123 | A2001 | Placebo | Placebo | Placebo | Placebo | 28JAN2021 |
| 21 |
|
|
...
...
|
| PRODUCT | Systolic Blood Pressure (mmHg) | SYSBP | 4 | 95 | 153 | -58 | -37.9085 |
|
| Y | Y | Y | 2021-01-08 | 2021-01-28 | 10 | SYSBP | Systolic Blood Pressure |
|
|
...
...
...
...
...
...
| A2001 | Placebo | Placebo | Placebo | Placebo | 28JAN2021 |
| 21 | Visit 2 | 2 |
|
|
...
|
| PRODUCT | Diastolic Blood Pressure (mmHg) | DIABP | 1 | 44 | 46 | -2 | -4.3478 |
|
| Y | Y | Y | 2021-01-08 | 2021-01-28 | 11 | DIABP | Diastolic Blood Pressure |
|
|
...
...
...
...
...
| A2001 | Placebo | Placebo | Placebo | Placebo | 28JAN2021 |
| 21 | Visit 2 | 2 |
|
|
...
|
| PRODUCT | Temperature (C) | TEMP | 5 | 36.2 | 35.45 | .75 | 2.1157 |
|
|
...
...
...
| Y | 2021-01-08 | 2021-01-28 | 12 | TEMP | Temperature |
|
|
...
|
|
| SUBLINGUAL REGION |
|
| 2 | Visit 2 |
|
|
...
...
...
...
| A2001 | Placebo | Placebo | Placebo | Placebo | 28JAN2021 |
| 21 |
|
|
...
...
|
| PRODUCT | Weight (kg) | WEIGHT | 6 |
|
|
...
...
| 13 | WEIGHT | Weight | NOT DONE | SUBJECT REFUSED |
|
|
| 2 | Visit 2 | 2021-01-28 | 21 |
|
|
|
|
| Definexmltable |
|---|
| Level | Dataset |
|---|
| Purpose | Analysis |
|---|
| Name | ADVS |
|---|
|
| Dataset | Description | Class | Structure | Purpose | Keys | Location | Documentation |
|---|
| ADVS | Vital Signs Analysis Dataset | BASIC DATA STRUCTURE | |
...
| One or more records per subject per analysis parameter per analysis visit per analysis timepoint | Analysis | STUDYID, USUBJID, PARAM, PARAMCD, AVISIT, ATPT | ADVS.xpt | ADVS.SAS/SAP |
|
| Definexmltable |
|---|
| Dataset | ADVS |
|---|
| Level | Variable |
|---|
| Purpose | Analysis |
|---|
|
| Variable Name | Variable Label | Type | Codelist/Controlled Terms | Core | Notes |
|---|
| Study Identifier | text |
| Req | VS.STUDYID | | USUBJID | Unique Subject Identifier | text |
| Req | VS.USUBJID | | TRTP | Planned Product | Char |
| Cond | ADSL.TRT01P | | TRT01P | Planned Product for Period 01 | Char |
| Cond | ADSL.TRT01P | | TRTA | Actual Product | Char |
| Cond | ADSL.TRT01A | | TRT01A | Actual Product for Period 01 | Char |
| Cond | ADSL.TRT01A | | ADT | Analysis Date | Num |
| Perm | VS.VSDTC captured as a date in numeric format. | | ADTM | Analysis Datetime | integer |
| Perm | VS.VSDTC captured as a datetime in numeric format. | | ADY | Analysis Relative Day | Num |
| Perm | VS.VSDY | | AVISIT | Analysis Visit | Char |
| Cond | VS.VISIT | | AVISITN | Analysis Visit (N) | Num |
| Perm | VS.VISITNUM | | ATPT | Analysis Timepoint | Char |
| Cond | VS.VSTPT | | ATPTN | Analysis Timepoint (N) | Num |
| Cond | VS.VSTPTNUM | | APHASE | Phase | Char |
| Perm | if ADT lt ADSL,TRTSDT then set to SCREENING, else if TRTSDT le ADT le TRTEDT then set to PRODUCT, else if ADT gt TRTEDT then set to FOLLOW-UP | | PARAM | Parameter | Char |
| Req | set to VS.VSTEST concatenated with VS.VSTRESU | | PARAMCD | Parameter Code | text |
| Req | set to VS.VSTESTCD | | PARAMN | Parameter (N) | Num |
| Perm | Numeric representation of PARAM. sort by VSTESTCD and increment by 1 for each unique value of VSTESTCD | | AVAL | Analysis Value | Num |
| Cond | VS.VSSTRESN for records taken from VS, Average of values taken on same datedataset. | | BASE | Baseline Value | Num |
| Cond | AVAL where ABLFL=Y | | CHG | Change from Baseline | Num |
| Perm | AVAL-BASE | | PCHG | Percent Change from Baseline | Num |
| Perm | ((AVAL-BASE)/BASE)*100 | | DTYPE | Derivation Type | Char | AVERAGE | Cond | set to AVERAGE for rows added to capture average value for parameters with multiple assessments done at a VISIT | | ABLFL | Baseline Record Flag | Char | Y | Cond | set to Y on the record that captures the baseline value | | ANL01FL | Analysis Flag 01 | Char | Y | Cond | set to Y on record chosen to represent AVISIT for analysis | | SAFFL | Safety Population Flag | Char | Y;N | Cond | ADSL.SAFFL | | RANDFL | Randomized Population Flag | Char | Y;N | Cond | ADSL.RANDFL | | TRTSDT | Date of First Exposure to Product | Num |
| Perm | ADSL.TRTSDT | | TRTEDT | Date of Last Exposure to Product | Num |
| Perm | ADSL.TRTEDT | | VSSEQ | Sequence Number | Num |
| Perm | VS.VSSEQ | | VISIT | Visit Name | Char |
| Perm | VS.VISIT | | VISITNUM | Visit Number | Num |
| Perm | VS.VISITNUM | | VSTPT | Planned Time Point Name | Char |
| Perm | VS.VSTPT | | VSTPTNUM | Planned Time Point Number | Char |
| Perm | VS.VSTPTNUM | |